CN108130370B - Psmb8及其抑制剂在制备治疗脂肪肝及其相关疾病药物中的应用 - Google Patents
Psmb8及其抑制剂在制备治疗脂肪肝及其相关疾病药物中的应用 Download PDFInfo
- Publication number
- CN108130370B CN108130370B CN201810012237.XA CN201810012237A CN108130370B CN 108130370 B CN108130370 B CN 108130370B CN 201810012237 A CN201810012237 A CN 201810012237A CN 108130370 B CN108130370 B CN 108130370B
- Authority
- CN
- China
- Prior art keywords
- psmb8
- fatty liver
- liver
- inhibitor
- related diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Oncology (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810012237.XA CN108130370B (zh) | 2018-01-05 | 2018-01-05 | Psmb8及其抑制剂在制备治疗脂肪肝及其相关疾病药物中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810012237.XA CN108130370B (zh) | 2018-01-05 | 2018-01-05 | Psmb8及其抑制剂在制备治疗脂肪肝及其相关疾病药物中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108130370A CN108130370A (zh) | 2018-06-08 |
CN108130370B true CN108130370B (zh) | 2020-11-17 |
Family
ID=62400407
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810012237.XA Active CN108130370B (zh) | 2018-01-05 | 2018-01-05 | Psmb8及其抑制剂在制备治疗脂肪肝及其相关疾病药物中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108130370B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111184864B (zh) * | 2020-01-20 | 2022-01-14 | 武汉大学 | Alox12特异性抑制剂在制备治疗非酒精性脂肪肝病和/或ⅱ型糖尿病的药物中的应用 |
WO2023238881A1 (ja) * | 2022-06-07 | 2023-12-14 | 日東電工株式会社 | 非アルコール性脂肪性肝疾患(nafld)または非アルコール性脂肪肝炎(nash)を診断するためのマーカー |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112014015363A2 (pt) * | 2011-12-22 | 2017-06-13 | Ares Trading Sa | derivados de ácido alfa-amino borônico, inibidores de imunoproteassoma seletivos |
WO2015195950A1 (en) * | 2014-06-20 | 2015-12-23 | Principia Biophamram Inc. | Lmp7 inhibitors |
-
2018
- 2018-01-05 CN CN201810012237.XA patent/CN108130370B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN108130370A (zh) | 2018-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Dong et al. | Circadian rhythm in pharmacokinetics and its relevance to chronotherapy | |
Roberts | The jaundiced baby | |
US11155638B2 (en) | Anti-CHI3L1 antibodies for the detection and/or treatment of nonalcoholic fattly liver disease/nonalcoholic steatonhepatitis and subsequent complications | |
CN108451964A (zh) | 白头翁皂苷b5在制备抗炎症性肠病药物中的应用 | |
KR20170132879A (ko) | 조합 요법을 위한 약제학적 조성물 | |
CN108130370B (zh) | Psmb8及其抑制剂在制备治疗脂肪肝及其相关疾病药物中的应用 | |
US7417175B2 (en) | Interstitial prostatism model animal | |
JP2008540537A (ja) | チアゾール化合物および使用方法 | |
EA028550B1 (ru) | Ингибитор грелин-o-ацилтрансферазы | |
JPWO2010134373A1 (ja) | メタボリックシンドロームの予防剤及び/又は治療剤 | |
CN105982881A (zh) | 一种补骨脂查尔酮及其类似物的用途 | |
CN101090717B (zh) | 甘氨酸在制备调节动物体重和体型的组合物中的用途 | |
CN103037901B (zh) | 抑制cd36以控制肥胖和胰岛素敏感性 | |
EP2647386B1 (en) | Lissencephaly therapeutic agent | |
CN115068480A (zh) | 细胞分裂周期蛋白42小分子抑制剂在制备治疗慢性肾脏病药物中的应用 | |
Chen et al. | Ample dietary fat reduced the risk of primary vesical calculi by inducing macrophages to engulf budding crystals in mice | |
WO2014167030A1 (en) | Anti-s100a7 antibodies for the treatment and diagnosis of cancer | |
Tang et al. | The role of ursodeoxycholic acid on cholestatic hepatic fibrosis in infant rats | |
US20220298255A1 (en) | E-cadherin activating antibodies and uses thereof | |
CN111184864B (zh) | Alox12特异性抑制剂在制备治疗非酒精性脂肪肝病和/或ⅱ型糖尿病的药物中的应用 | |
EP4272580A2 (en) | A ferrous amino acid chelate for use in alleviating kidney disease and fibrosis of organ | |
KR102176937B1 (ko) | 바이페린 억제제를 유효성분으로 포함하는 대사질환의 예방 또는 치료용 조성물 | |
CN101703523A (zh) | 一种抗肝纤维化有效剂型的制备方法 | |
Arra | PANCREATIC IMMUNE CELL ALTERATIONS IN AN ANIMAL MICE MODEL OF LIVER FIBROSIS | |
Al Sereidi | DISTRIBUTION OF ERM PROTEINS IN THE STOMACH MUCOSA OF NORMAL AND DIABETIC RATS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20200417 Address after: 430072 room 01, floor 14, unit B, building 1, Optical Valley International Building, No. 2-2, guandongyuan Road, Donghu high tech Development Zone, Wuhan City, Hubei Province Applicant after: Wuhan yamet Technology Co., Ltd Address before: 430072 Hubei Province, Wuhan city Wuchang District of Wuhan University Luojiashan Applicant before: WUHAN University |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20200520 Address after: 430000 16 / F, building 02, phase III, software new town, No.8 Huacheng Avenue, Donghu New Technology Development Zone, Wuhan City, Hubei Province Applicant after: Wuhan huikangda Technology Co., Ltd Address before: 430072 room 01, floor 14, unit B, building 1, Optical Valley International Building, No. 2-2, guandongyuan Road, Donghu high tech Development Zone, Wuhan City, Hubei Province Applicant before: Wuhan yamet Technology Co., Ltd |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant |